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all treatment approaches, was 5.2% (95% CI 
5-5.5%), 3.9% (95% CI 3.4-4.4%) and 7.8%
(95% CI 7.2-8.5%) respectively. For patients
that underwent surgery, the 5-year survival
for patients with lesions in all locations, head,
body and tail was 18.8%, 15.9%, 23.8%
and 33.8% respectively. When analyzing
trends we noted a significant improvement in
survival for patients that underwent operative
intervention. Comparing the time periods 
from 1977-1981 versus 2002-2006, the 5-year 
survival for surgical patients improved for 
all locations (9.2% to 22.6%, p<0.05) and 
also for lesions in the head (8.3% to 19.3%, 
p<0.05), body (6.7% to 26%, p<0.05) and tail 
(14.7% to 40.7%, p<0.05). 
Conclusion: The results of our study 
demonstrate an improvement in survival for 
patients with pancreatic cancer treated by 
operative intervention. This improvement in 
survival was more pronounced for patients 
with primary lesions located in the body and 
tail. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.044
Global Trends in Esophageal Cancer
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Background & Objectives: Esophageal 
Cancer (EC) is a lethal malignancy with poor 
prognosis and significant variations in the 
incidence, mortality, and histopathology based 
on geographic regions. The aim of this study 
was to quantitatively analyze these variations 
to identify patterns and areas for further 
research.
Methods: We utilized the GLOBOCAN 2012, 
and Cancer Incidence in five Continents, 
Volume X (CI5X) database to analyze 
variations in EC incidence and mortality.
Results: We found the EC incidence and 
mortality is geographically varied with a 
particularly high burden in East Asia and 
Eastern/Southern Africa where esophageal 
squamous cell carcinoma (SCC) predominates 
over adenocarcinoma (AC). Interestingly, 
there is a dichotomy between the high 
incidence of esophageal SCC in East Africa 
and low incidence in West Africa. The global 
incidence and mortality from EC is expected 
to rise in the coming decades. Asia, and 
China in particular, will continue to be the 
areas most burdened by EC, while Africa 
is expected to surpass the incidence and 
mortality rates of Europe.
Conclusions: The global burden of EC 
is expected to rise in the coming years. 
Understanding the geographic, environmental, 
and genetic contributors to the development 
of EC will be essential in combating its 
prevalence. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.045
Outcomes of Intragastric Balloon Placements: An Analysis of the 2016 MBSAQIP Database
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Background & Objectives: Intragastric 
balloon placement is an approved weight-
loss procedure with a lower BMI cutoff than 
bariatric surgery. The objective of this study 
was to examine the frequency and outcomes 
of balloon placements in 2016.
Methods: The MBSAQIP database was 
analyzed for adults who underwent elective, 
endoscopic intragastric balloon placement. 
Emergent cases, patients with previous foregut 
surgery and those unable to be followed for 
30 days were excluded. Comparisons were 
made between placements performed by GI 
and surgery. Analysis performed using SPSS 
v25.0, α=.05. 
Results: Our study included 445 patients. 
Majority were female (80%) and Caucasian 
(90.6%). Median age and BMI were 49.0 
(IQR 15.4) and 35.7 (IQR 6.46), respectively. 
Prevalence of medically treated hypertension 
was 30.8%, hyperlipidemia 18.9%, GERD 
20.4%, and diabetes 12.6% (insulin and 
non-insulin dependent). Mean operative 
time was 15.48 ± 9.89 minutes. No 30-day 
mortalities were reported. 70 balloons were 
placed by GI and 375 by surgery. There was a 
significantly higher rate of readmission for GI 
7.1% vs 1.9% surgery (p=.027). No significant 
difference was seen for rates of post-operative 
dehydration (GI: 7.1% vs surgery: 7.2%; 
p=1.000), emergency room encounters (GI: 
14.0% vs surgery: 4.0%; p=.486), 30-day 
reoperations (GI: 0.0% vs surgery: 0.8%; 
p=1.000), and 30-day reinterventions (GI: 
5.7% vs surgery 2.4%; p=.132). 
Conclusions: The majority of patients 
undergoing intragastric balloon placement 
fall within obesity class 1 or 2 and have low 
rates of comorbidities. The procedure can be 
performed by gastroenterology or surgery at 
bariatric centers with similar outcomes.  
https://doi.org/10.32873/unmc.dc.gmerj.1.1.046
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Introduction: Noncompressible truncal 
hemorrhage and brain injury account for most 
early mortality in military personnel on the 
battlefield. Currently there is no effective 
treatment for noncompressible truncal 
hemorrhage, other than rapid evacuation to 
a surgical facility. We intended to develop a 
porcine model of noncompressible truncal 
hemorrhage so that we might be able to 
develop new treatments for this clinical 
problem. 
Methods: Swine (boars, 3 months, 32-34 kg) 
underwent one of three injury types: 1) central 
stellate injury, just anterior to suprahepatic 
inferior vena cava (N=6); 2) excision of a 
portal vein branch distal to the main trunk 
(N=5); or 3) near-transection of the left lateral 
lobe (LLL) of the liver at its base, which 
cut the hepatic and portal veins to this lobe 
(N=12). The midline incision was towel 
clipped immediately after injury, and animals 
were monitored for 60 min or until death. 
Resuscitation was performed with warm LR 
(max volume = 100 mL/kg), with a target 
MAP set at 80% of pre-injury MAP. 
Results: The starting weight, MAP, 
hemoglobin, arterial pH, INR, and pre-injury 
blood loss did not differ among groups (p 
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> 0.05, ANOVA). Postmortem evaluation
revealed that 2-3 hepatic veins were
transected by injury type 1, 1-2 portal vein
branches plus 1 hepatic vein were transected
by injury type 3 (LLL transection).
Conclusions: The hemorrhage severity of the 
central stellate injury was inadequate, while 
hemorrhage from excision of a proximal 
branch of the portal vein appeared to be too 
severe (i.e., the subjects died too quickly). 
Near-transection of the hepatic LLL at its base 
appeared to yield hemorrhage of appropriate 
severity, as indicated by the 40% 1-hour 
mortality and intermediate values for MAP, 
blood loss, and other variables. Our plan is to 
use this latter injury model in the development 
of therapies for noncompressible truncal 
hemorrhage. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.047
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Exogenous Testosterone Supplementation as Cause of Ischemic Stroke, Mediated through 
Secondary Erythrocytosis
Fuad-al Ali, Amy Hellman, Pierre Fayad
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Program: Neurology
Background: The use of exogenous 
testosterone has become more prevalent in 
recent years but the effects of such use in 
regards to potential cerebrovascular disease 
have yet to come to a conclusion. In this case 
report, we discuss a patient who suffered 
an ischemic stroke due to testosterone 
supplementation.
Case presentation: A middle-aged 
patient with history of hypertension and 
hyperlipidemia that presented with falls, 
difficulty performing simple tasks and slurred 
speech. Patient had been taking testosterone 
injections every 6 months for the prior 2 years 
for loss of energy and reported low levels. 
Lab work revealed a hemoglobin of 20 g/dL 
and a hematocrit of 51.5%. MRI of the brain 
showed a left striatocapsular ischemic infarct. 
He was given the diagnosis of ischemic stroke 
due to polycythemia and thrombus formation 
secondary to testosterone supplementation. 
Discussion: Testosterone and 
dihydrotestosterone (DHT) has both 
protective and adverse effects. Both low and 
high levels of testosterone and DHT have an 
association with ischemic stroke and there 
may be an optimal level that is safe. 
Conclusion: The risk of ischemic stroke may 
be related to testosterone and DHT levels but 
no clear guidelines exist on optimal levels 
in supplementation. Thus, clinicians should 
be aware of the potential risk and monitor 
androgen and hematocrit levels. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.048
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Objective: To assess the effectiveness of 
treatment for status epilepticus (SE) at UNMC 
and determine patient health outcomes related 
to the delayed control of seizures 
Design/Methods: Retrospective chart 
review was performed on 1565 adult 
patients who underwent continuous video 
electroencephalography (cvEEG) for 
suspected seizures between January 1, 2012 
and February 28, 2018. 
Results: 49 patients had and were treated for 
64 incidences of convulsive or nonconvulsive 
SE recorded on cvEEG or clinical seizures 
longer than 5 min which were documented by 
a neurologist. Among 64 cases, 55 incidences 
required the second AED treatment, and 
40 out of 55 cases were treated with the 
third AED subsequently. The mean seizure 
detection-to-needle time for the first, 
second, and third antiepileptic drugs were 
167, 239, and 297 minutes, respectively. 
Benzodiazepines were administered as the 
first AED in only 46 % of all treated cases. 
The duration of the hospital stays in patients 
treated with the first AED within 60 min after 
seizure detection was shorter compared to 
those whose treatment was delayed (23.0 vs. 
33.6 days, p=0.41). The mortality rate in the 
former group was lower than that in the group 
which did not receive AEDs within 60 min 
(28.6 vs. 53.6%, p=0.02). 
Conclusion: The current treatment approaches 
for SE at UNMC are inefficient with 
significant delay in delivery of medications 
after seizure detection; they may contribute 
to the prolonged hospital stay and increased 
mortality. In order to improve patient care, the 
existing protocol for the treatment of SE at 
UNMC must be revised. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.049
A Clinical and Cost Effectiveness Comparison of Traditional VNS Therapy to Aspire Sr (106)
Krishna Mourya Galla, Kalyan Sajja, Christopher Wichman, Hongmei Wang, Deepak Madhavan
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Background: VNS Therapy has demonstrated 
overall cost savings in patients with drug-
51 
resistant epilepsy. The overall goal of this 
project is to evaluate the clinical and cost 
effectiveness of the Aspire SR 106 VNS 
(Vagus Nerve Stimulator) system, using 
retrospective patient data. We anticipate 
the extra dimension of closed-loop 
autostimulation in the Aspire 106 model will 
demonstrate more efficient utilization of 
health care resources. 
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